Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Older than 18 years~* Wexner's fecal incontinence score \> or egal 5~* patient who has fecal incontinence for more than 6 months~* Continuity of anal sphincter at endorectal ultrasound and abnormality of anal function at anorectal manometry~* negative for urine beta-HCG for woman of childbearing age~* agreement to participate, with signed informed-consent~Exclusion Criteria:~* Anorectal surgery within the last 6 months prior to the study~* patient who is allergy to bovine-derived materials and an anesthetic~* patients with a diagnosis of auto immune disease~* Diagnosis of HBV, HCV, HIV and other infectious disease~* Patients with a diagnosis of active Tuberculosis~* Patient is pregnant or breast-feeding~* Women within 6 months post partum~* Patient who is unwilling to use an effective method of contraception during the study~* Patients with a diagnosis of Inflammatory Bowel Disease~* Patient who has a clinically relevant history of abuse of alcohol or drugs~* Insufficient adipose tissue for manufacturing of ANT-SM~* Patient whom investigator consider is not suitable in this study~* Patients have history of surgery for malignant cancer in the past 5 years~* Patient who has to undergo ano-rectal surgery~* Patient who has a history of artificial anal sphincter surgery~* Patient who has taken cytotoxic drugs within the last 30 days~* Patient whom investigator consider is not suitable in this study reasons for severe ano-rectal disease, severe constipation, fistula, rectal prolapsed or neurological diseases (spinal cord injury, multiple sclerosis, Parkinson's disease)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ANT-SM (Type: EXPERIMENTAL): autologous adipose-derived stem cell

Based on this trial design, predict the completion outcome and termination type (if applicable).